Toxoplasmosis.
D003141:Communicable Diseases; D003168:Complement Fixation Tests; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011739:Pyrimethamine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy / Q000453:epidemiology
D007933:Leucomycins; D013449:Sulfonamides; D011739:Pyrimethamine